Pharmaceutical Biology
Volume 62, 2024 - Issue 1
Open access
847
Views
0
CrossRef citations to date
0
Altmetric
Research Article
Tabersonine enhances cisplatin sensitivity by modulating Aurora kinase A and suppressing epithelial–mesenchymal transition in triple-negative breast cancer
Xi Chena Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaView further author information
, Yuanliang Yana Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaView further author information
, Yuanhong Liua Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaView further author information
, Qiaoli Yia Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaView further author information
& Zhijie Xub Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, China;c National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaCorrespondence[email protected]
View further author information
View further author information
Pages 394-403
|
Received 07 Dec 2023, Accepted 28 Apr 2024, Published online: 13 May 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.